Cardiomyopathy is a leading cause of death in patients with Duchenne muscular dystrophy. Congestive heart failure is often subclinical and unrecognized as a result of the severe physical limitations of this patient population. We report the case of a 16-year-old boy with Duchenne muscular dystrophy who demonstrated normal left ventricular systolic function at rest by screening transthoracic echocardiogram. This patient, however, was noted to have depressed left ventricular contractile reserve by dobutamine stress echocardiography. Dobutamine stress echocardiography can have an important role in unmasking subclinical heart failure in this patient population. (J Child Neurol 2005;20:246—248).
Get full access to this article
View all access options for this article.
References
1.
Emery Aeh.Population frequencies of inherited neuromuscular diseases—a world survey . Neuromuscul Disord1991;1:19-29.
2.
Perloff J., deLeon A., O'Doherty D.: The cardiomyopathy of progressive muscular dystrophy. Circulation1966;33:625—648
3.
Lampert M., Weinert L., Hibbard J., et al: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol1997;1:181—195.
4.
Kitaoka H., Takata J., Yabe T., et al: Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy. Heart1999;81:523—527.
5.
Naqvi T., Goel R., Forrester J., Siegel R.: Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset dilated cardiomyopathy. J Am Coll Cardiol1999;34:1537—1544.
6.
Pasquet A., Lauer M., Williams M., et al: Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Eur Heart J2000;21:125—136.
7.
Klewer S., Goldberg S., Donnerstein R., et al: Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol1992;19:394—401.
8.
De Wolf D., Suys B., Maurus R., et al: Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer surviors. Pediatr Res1996;39:504—512.
9.
Nigro G., Comi L., Politano L., Bain R.: The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy . Int J Cardiol1990;26:271—277.
10.
Ramaciotti C., Scott W., Lemler M., et al: Assessment of cardiac function in adolescents with Duchenne muscular dystrophy: Importance of neurohormones . J Child Neurol2002;17:191—194.
11.
Lanza G., Russo A., Giglio V., et al: Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: Relationship to myocardial and respiratory function. Am Heart J2001;141:808—812.
12.
Michelfelder E., Witt S., Khoury P., Kimball T.: Moderate-dose dobutamine maximizes left ventricular contractile response during dobutamine stress echocardiography in children . J Am Soc Echocardiogr2003;16:140—146.
